Log in

OTCMKTS:NICXFNicOx Stock Price, Forecast & News

$4.82
0.00 (0.00 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.82
Now: $4.82
$4.82
50-Day Range
$4.23
MA: $4.58
$4.82
52-Week Range
$4.13
Now: $4.82
$5.91
VolumeN/A
Average Volume3 shs
Market Capitalization$161.33 million
P/E RatioN/A
Dividend YieldN/A
Beta0.57
Nicox S.A., an ophthalmic company, researches, develops, and markets therapies that target various ophthalmic conditions in France and internationally. The company's product pipeline includes VyzultaTM, an intraocular pressure-lowering treatment; and NCX 470, a nitric oxide (NO)-donating candidate to treat glaucoma, as well as stand-alone NO donors for specific applications in ophthalmic diseases. It also develops ZERVIATE, an eye drop formulation of cetirizine for allergic conjunctivitis; NCX 4280, an ophthalmic solution that targets morning ocular congestion; and NCX 4251, a patented formulation of fluticasone propionate to treat blepharitis. The company has collaborations with Bausch + Lomb, Astra Zeneca, Merck, Pfizer, and Ironwood Pharmaceuticals, Inc., as well as Novaliq GmbH. Nicox S.A. was founded in 1996 and is headquartered in Valbonne, France.
Read More
NicOx logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.51 out of 5 stars


Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NICXF
Previous SymbolNASDAQ:NICXF
CUSIPN/A
CIKN/A
Phone33-4-97-24-53-00

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees31
Market Cap$161.33 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NICXF News and Ratings via Email

Sign-up to receive the latest news and ratings for NICXF and its competitors with MarketBeat's FREE daily newsletter.

NicOx (OTCMKTS:NICXF) Frequently Asked Questions

How has NicOx's stock been impacted by COVID-19 (Coronavirus)?

NicOx's stock was trading at $4.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NICXF stock has increased by 10.8% and is now trading at $4.82. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of NicOx?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NicOx in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for NicOx.

Has NicOx been receiving favorable news coverage?

Headlines about NICXF stock have been trending negative recently, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. NicOx earned a daily sentiment score of -2.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about NicOx.

Who are some of NicOx's key competitors?

Who are NicOx's key executives?

NicOx's management team includes the following people:
  • Mr. Michele Garufi, Co-Founder, Chairman & CEO (Age 65)
  • Ms. Sandrine Gestin, VP of Fin. (Age 52)
  • Dr. Michael V. W. Bergamini, Chief Scientific Advisor (Age 72)
  • Mrs. Emmanuelle Pierry, Sr. Director of Legal Affairs
  • Dr. Gavin Spencer, Exec. VP, Chief Bus. Officer & Head of Corp. Devel. (Age 49)

What is NicOx's stock symbol?

NicOx trades on the OTCMKTS under the ticker symbol "NICXF."

How do I buy shares of NicOx?

Shares of NICXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NicOx's stock price today?

One share of NICXF stock can currently be purchased for approximately $4.82.

How big of a company is NicOx?

NicOx has a market capitalization of $161.33 million. NicOx employs 31 workers across the globe.

What is NicOx's official website?

The official website for NicOx is www.nicox.com.

How can I contact NicOx?

NicOx's mailing address is Drakkar 2 - Batiment D 2405 route des Dolines - CS 10313 Sophia Antipolis Cedex, Valbonne I0, 06560. The company can be reached via phone at 33-4-97-24-53-00.

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.